Drugs and biologicals
Ended Awarded Last action
- Contract number
- HHSN26300142
- Awardee
-
Roche Diagnostics Corporation UEI JDMDFEZBYH36
- Awarding agency
-
Office of the Director
National Institutes of Health, Department of Health and Human Services
- Obligated
- $6,866
Award facts
- Contract value 68% obligated
-
- $6,866.26 Current, with exercised options
- $10,074.92 Potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Indianapolis, IN 46250, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | $3,658 | |
| Original award | $3,209 |
About this award
This federal contract award is for DRUGS AND BIOLOGICALS, with a ceiling value of $10,074.92, awarded to Roche Diagnostics Corporation, a foreign-owned, for-profit manufacturer of in vitro diagnostics, reagents, and medical equipment. The contract was awarded on July 9, 2014, with an ultimate completion date of December 31, 2014. The contract type is a Blanket Purchase Agreement (BPA) Call and has a Firm Fixed Price pricing type. The funding federal agency is the Office of the Director, a civilian agency.
The contract award is not designated as a set-aside. Roche Diagnostics Corporation holds multiple significant Indefinite Delivery Contracts (IDCs) and BPAs across federal agencies, including a $37 million BPA with the Defense Health Agency for immunochemistry and clinical chemistry testing, and several VA-specific IDCs. These contract vehicles enable federal agencies to efficiently acquire Roche's medical diagnostic technologies through pre-negotiated pricing and terms, supporting healthcare delivery across military, veterans, and civilian healthcare systems.
Quick answers
Who was awarded contract HHSN26300142?
HHSN26300142 was awarded to Roche Diagnostics Corporation by Office of the Director (National Institutes of Health) on July 9, 2014.
How much is contract HHSN26300142 worth?
The government has obligated $6,866 on HHSN26300142. Its potential value, with all options, is $10,075.
Is contract HHSN26300142 an order under another contract?
Yes. HHSN26300142 is a BPA call under HHSN263200400060630B, a blanket purchase agreement.
Was contract HHSN26300142 competed?
The extent of competition for HHSN26300142 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award